Jean-Louis Kraus

Can artificial intelligency revolutionize drug discovery?

Jean-Louis Kraus, J. Kraus, 2019, AI & SOCIETY.

A new Met inhibitory-scaffold identified by a focused forward chemical biological screen.

Bernard Maigret, Vincent Leroux, Jean-Louis Kraus, 2008, Biochemical and biophysical research communications.

New protease inhibitors prevent γ-secretase-mediated production of Aβ40/42 without affecting Notch cleavage

Olivier Pourquié, Jean-Louis Kraus, O. Pourquié, 2001, Nature Cell Biology.

Synthesis of new covalently bound kappa-carrageenan-AZT conjugates with improved anti-HIV activities.

Myriam Witvrouw, Christophe Pannecouque, Jean-Louis Kraus, 2002, Journal of medicinal chemistry.

Prospects for the resistance to HIV protease inhibitors: current drug design approaches and perspectives.

Jean-Louis Kraus, J. Kraus, C. Garino, 2005, Current pharmaceutical design.

BACE-1 inhibitory activities of new substituted phenyl-piperazine coupled to various heterocycles: chromene, coumarin and quinoline.

Jean-Louis Kraus, Gilles Quéléver, Nicolas Pietrancosta, 2006, Bioorganic & medicinal chemistry letters.

Synthesis and biological activity of phosphonate analogues and geometric isomers of the highly potent phosphoantigen (E)-1-hydroxy-2-methylbut-2-enyl 4-diphosphate.

Christian Belmant, Jean Dessolin, Jean-Louis Kraus, 2008, Journal of medicinal chemistry.